Dec 31 • 06:33 UTC 🇨🇿 Czechia Deník N

In 2025, European tech firms thrived on the stock exchange; the Danish king of pharmaceutical companies struggled

In 2025, while American tech giants excelled in the AI competition, the European market showcased a diverse range of high-cap companies, with significant variances in stock performance, particularly struggling for Novo Nordisk.

📡 Similar Coverage